A. Bader et al., TACROLIMUS (FK-506) BIOTRANSFORMATION IN PRIMARY RAT HEPATOCYTES DEPENDS ON EXTRACELLULAR-MATRIX GEOMETRY, Naunyn-Schmiedeberg's archives of pharmacology, 353(4), 1996, pp. 461-473
Established in vitro models for studies of hepatic drug biotransformat
ion include the use of primary hepatocytes. In normal liver the space
of Disse provides the possibility of bilateral attachment to extracell
ular matrix for each hepatocyte. This configuration is disrupted by th
e cell isolation procedure of normal liver tissue, which delivers susp
ensions of round shaped cells. In standard culture configurations this
unphysiologic cell shape terminates in a morphological dedifferentiat
ion and inability to biotransform drugs. This study analyses the relev
ance of extracellular matrix geometry in hepatocyte monolayer configur
ations for expression and activity of cytochrome P450 3A. This enzyme
is involved in the biotransformation of a large number of pharmaceutic
als including the immunosuppressants tacrolimus and sirolimus. Morphol
ogical analysis of primary rat hepatocytes cultured with and without o
verlay of collagen type I was performed by transmission and scanning e
lectron microscopy. Expression and activity of cytochrome P450 3A was
studied by Western blot and the use of two model drugs specific for th
is enzyme. To this purpose the immunosuppressive drugs tacrolimus and
sirolimus were used. Metabolites were analyzed by HPLC and HPLC/MS. Tw
o sided attachment to extracellular matrix induces profound changes of
the hepatocellular morphology in vitro resulting in the reconstitutio
n of a polyhedric cell shape. This phenomenon is paralleled by an enha
nced expression of cytochrome P450 3A and corresponding metabolic acti
vity. As shown for tacrolimus biotransformation, the model may be usef
ul to study complex metabolic patterns. In addition this model may fac
ilitate studies of the kinetics of hepatocellular drug biotransformati
on in a setting with prolonged stability.